[1] Ding L, Zhao Y, Dang S, et al. Circular RNA circ-DONSON facilitates gastric cancer growth and invasion via NURF complex dependent activation of transcription factor SOX4[J]. Mol Cancer, 2019, 18: 45.doi:10.1186/S12943-019-1006-2. [2] Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68: 394-424. [3] Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017[J]. CA Cancer J Clin, 2017, 67: 7-30. [4] Hu X, Zhang M, Miao J, et al. miRNA-4317 suppresses human gastric cancer cell proliferation by targeting ZNF322[J]. Cell Biol Int, 2018, 42: 923-930. [5] Link A, Kupcinskas J. MicroRNAs as non-invasive diagnostic biomarkers for gastric cancer: Current insights and future perspectives[J]. World J Gastroenterol, 2018, 24: 3313-3329. [6] Zhang C, Bo C, Guo L, et al. BCL2 and hsa-miR-181a-5p are potential biomarkers associated with papillary thyroid cancer based on bioinformatics analysis[J]. World J Surg Oncol, 2019, 17: 221.doi:10.1186/S12957-019-1755-9. [7] Xue J, Chi Y, Chen Y, et al. MiRNA-621 sensitizes breast cancer to chemotherapy by suppressing FBXO11 and enhancing p53 activity[J]. Oncogene, 2016, 35: 448-458. [8] Zhang Y, You W, Zhou H, et al. Downregulated miR-621 promotes cell proliferation via targeting CAPRIN1 in hepatocellular carcinoma[J]. Am J Cancer Res, 2018, 8: 2116-2129. [9] Skawran B, Steinemann D, Becker T, et al. Loss of 13q is associated with genes involved in cell cycle and proliferation in dedifferentiated hepatocellular carcinoma[J]. Mod Pathol, 2008, 21: 1479-1489. [10] Song Z, Wu Y, Yang J, et al. Progress in the treatment of advanced gastric cancer[J]. Tumour Biol, 2017, 39.doi:10.1177/1010428317714626. [11] Li W, Li J, Mu H, et al. miR-503 suppresses cell proliferation and invasion of gastric cancer by targeting HMGA2 and inactivating WNT signaling pathway[J]. Cancer Cell Int, 2019, 19: 164.doi:10.1186/S12935-019-0875-1. |